Warburg Pincus
http://www.warburgpincus.com/Warburg Pincus has been a leading private equity investor since 1971. Since its inception, Warburg Pincus has invested $29 billion in 585 companies in 30 countries across a range of sectors, including healthcare, consumer and retail, industrial, financial services, energy, real estate, technology, media, and telecommunications.
-
Fitch Affirms & Withdraws Primerica Life's IFS at 'A+'; Outlook Stable
-
Total Safety Partners With Serve Moore to Support Victims of Devastating Oklahoma Tornado
-
Market Wrap: Initial Claims Near 5-Year Low; Gannett's Smart Buy; Eau de Coty
-
Warburg Pincus Holding Antero Resources (AR) Files for $1B IPO
-
Form 4 Primerica, Inc. For: Jun 03 Filed by: WARBURG PINCUS & CO.
-
Form SC 13D/A Primerica, Inc. Filed by: Warburg Pincus Private Equity X, L.P.
-
Life Sciences IPOs Have Biggest Month in 13 Years, Burrill & Company Says
-
Chief Executive Magazine Names Honeywell CEO David Cote 2013 CEO of the Year
-
Form SC 13D/A Nuance Communications, Filed by: Warburg Pincus Private Equity VIII, L.P.
-
Banco Santander Chile Announcement regarding an offer for its Asset Management business
-
Grupo Financiero Santander Mexico Announces That Its Parent Company, Banco Santander, S.A., Has Reached An Agreement To Grow Its Asset Management Division
-
Neiman Marcus Rebuffs KKR's Proposed Merger with Saks (SKS); No Deal Might be End Result
-
Form SC 13D/A Primerica, Inc. Filed by: Warburg Pincus Private Equity X, L.P.
-
Primerica Announces Repurchase of Remaining Shares Held by Warburg Pincus
-
Notable Mergers and Acquisitions of the Day 05/28: (VRX) (ARCP)/(LSE) (FNF)/(LPS) (AZN)/(OMTH)
-
Valeant (VRX) Acquires Bausch + Lomb for $8.7 Billion
-
Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion
-
Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion
-
Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
-
First Manhattan Adds Alex Denner to Vivus Board Slate
-
Brainloop Names Bernhard Wöbker to Serve as CEO
-
Form SC 13D/A WEBSTER FINANCIAL CORP Filed by: Warburg Pincus Private Equity X, L.P.
-
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
-
Form SC 13G/A Targa Resources Corp. Filed by: Warburg Pincus Private Equity VIII, L.P.
-
Form 13F-HR WARBURG PINCUS LLC For: Mar 31
-
Turnitin to Participate in Google I/O on May 16, 2013
-
Warburg Pincus Raises $11.2B for New Global Private Equity Fund
-
Warburg Pincus Closes $11.2 Billion Global Private Equity Fund
-
Tornier Announces Pricing of Public Offering of Ordinary Shares
-
Form SC 13D/A WEBSTER FINANCIAL CORP Filed by: Warburg Pincus Private Equity X, L.P.
-
The New York Digital Health Accelerator Showcases Inaugural Class at Demo Day
-
Warburg Pincus Prices Offering of Shares of Webster
-
Webster Financial (WBS) Announces 8.74M Share Secondary Offering
-
Webster Financial Corporation Announces Secondary Offering
-
Tornier (TRNX) Commences 7M Common Stock Follow-On Offering
-
Tornier Announces Follow-on Offering of Ordinary Shares
-
Large Warburg Pincus Holding Antero Resources to File IPO
-
First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
-
First Manhattan Comments on Addition to Vivus’ Board of Directors
-
Form SC 13D/A China Biologic Products, Filed by: Warburg Pincus Private Equity X, L.P.
-
Guangdong Zhenrong and Warburg Pincus in Dispute
-
Avon Announces Changes to Board of Directors
-
Turnitin Launches Interactive Website that Rates Student Research Sources
-
KKR (KKR) to Acquire Majority Stake in Alliance Tire Group
-
Liberty (LBTYA) Takes Large Stake in Netherlands-Based Ziggo NV
-
FIS (FIS) Stockholder Seeks Sale of 19.3 Million Shares in Secondary Offering
-
Warburg Said to Pick JPMorgan to Lead Massive Bausch & Lomb IPO
-
WNS Limited (WNS) Stakeholder to Sell 12.6M ADS at $12.75/Share
-
Market Wrap: FOMC May End QE Early; Transocean Settles Up; Bausch & Lomb Draws Attention
-
Warburg Pincus Seeks to Sell Bausch & Lomb for $10B
